samedan logo
 
 
spacer
home > pmps > winter 2021 > safe, flexible, and efficient containment
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Safe, Flexible, and Efficient Containment

The demand for, and development of, new oral solid dosage forms for oncology and hormone therapy is increasing – and so is the demand for containment solutions. When processing these highly potent substances, the protection of machine operators is paramount. At the same time, the quality of the final product is crucial since patients' health depends on it.

But how much containment is really necessary, and how can it be implemented economically and flexibly in the cost-intensive pharmaceutical industry? Ultimately, only a combination of modern and highly efficient systems with automated cleaning, proven processes, and years of expertise form the basis for successful containment.

NOEL, OEL, and OEB

The occupational exposure limit (OEL) for active substances can be determined in micrograms per cubic metre (μg/m3) by means of no observed effect level (NOEL) and the required safety factors. The OEL is the time-weighted average concentration of a substance in the air at the workplace, at which no acute or chronic damage to the health of employees is to be expected. The regulation is based on eight-hour exposure five days a week during working life.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Fritz-Martin Scholz is Product Manager for the product brand Hüttlin at Syntegon Technology. The Hüttlin portfolio includes high-shear mixer granulator systems and fluid bed systems from laboratory to production scale. Fritz-Martin holds a Master’s in Engineering and has many years of experience in R&D, product development, and product management in different industries, such as packaging technology and medical technology.
spacer
Fritz-Martin Scholz
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Advanced Clinical Continues Global Expansion Into Asia-Pacific With New Office in Australia

Advanced Clinical, a global clinical research services organization, continues to build upon its growth strategy in the Asia-Pacific (APAC) region with the opening of a new office in Sydney, Australia.
More info >>

White Papers

The Power of Execution in Clinical Research

Medpace

Medpace, long known for its excellence in conducting Phase I-IV studies on a global platform, is particularly noted for its therapeutic excellence. When that expertise is combined with operational precision, the results are nothing short of stellar. The Medpace full-service outsourcing approach – combined with therapeutic expertise, regulatory know how, and global presence – delivers clinical studies with an industry recognized track record.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement